Status:
UNKNOWN
Vaccination Against COVID-19 in Chronic Kidney Disease
Lead Sponsor:
Heinrich-Heine University, Duesseldorf
Conditions:
Chronic Kidney Disease Stage 5 on Dialysis
Chronic Kidney Disease Stage 5 With Transplant
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, multi-center, observational study that will enroll patients receiving dialysis (hemodialysis or peritoneal dialysis) or patients with kidney transplantation who will be vaccinat...
Detailed Description
Patients on dialysis and kidney transplant patients infected with SARS-CoV-2 (severe acute respiratory syndrome coronavirus type 2) have an increased risk to develop a more severe course of disease or...
Eligibility Criteria
Inclusion
- receiving dialysis (hemodialysis or peritoneal dialysis)
- capable of giving consent
- age 18 or older
Exclusion
- \- non-capable of giving consent
Key Trial Info
Start Date :
December 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04743947
Start Date
December 21 2020
End Date
December 31 2025
Last Update
January 10 2022
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
MVZ DaVita Rhein-Ruhr
Düsseldorf, Germany, 40210
2
KfH Kuratorium für Dialyse und Nierentransplantation e.V.
Düsseldorf, Germany, 40225
3
University Hospital Düsseldorf, Heinrich Heine University
Düsseldorf, Germany, 40225
4
Nephrocare Mettmann
Mettmann, Germany, 40822